The review suggests the study on male pattern baldness needs to improve in areas like sample size, methodology, and bias for better quality and credibility.
April 2024 in “Human genomics” Identified genes linked to male-pattern baldness may help develop new treatments.
February 2024 in “Buletin Veteriner Udayana” The dog with severe hair loss and itching improved after treatment for ehrlichiosis and demodicosis.
January 2024 in “Research Square (Research Square)” The research identified genes linked to male-pattern baldness and potential drug targets for treatment.
January 2024 in “International Ayurvedic medical journal” Certain Prakruti types are more prone to early male pattern baldness.
January 2024 in “Springer eBooks” Modern hair restoration techniques offer natural results with minimal complications.
October 2023 in “Acta dermato-venereologica” Minoxidil and platelet-rich plasma can help turn thin hair into thicker hair in male pattern baldness.
July 2023 in “Turkish journal of veterinary research” Wild boar bristles in Balıkesir vary in length and thickness but are unsuitable for species separation.
April 2023 in “Jordan Medical Journal” Men with male pattern baldness are more likely to have benign prostatic hyperplasia.
The document is about planning a review to assess if PRP alone is effective for treating hair loss in men and women.
April 2021 in “Journal of Investigative Dermatology” A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.
April 2020 in “Journal of the Endocrine Society” Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.
Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.
September 2019 in “IP Indian journal of clinical and experimental dermatology” Hormones and iron deficiency are linked to female pattern hair loss, and hair thinning patterns are similar across different types of this condition.
September 2018 in “Journal of The American Academy of Dermatology” The study concluded that a new method can effectively assess scalp sun damage in balding men, which increases with age and sun exposure.
January 2018 in “프로그램북(구 초록집)” Botulinum toxin type A is a safe and effective treatment for male pattern baldness.
June 2017 in “Journal of The American Academy of Dermatology” The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.
August 2016 in “Journal of Investigative Dermatology” Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.
August 2016 in “Journal of Investigative Dermatology” DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.
July 2016 in “Cancer Research” Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.
November 2015 in “Hair transplant forum international” Rosemary oil might help with male pattern baldness.
November 2015 in “Hair transplant forum international” PRP may help with hair regrowth in male pattern baldness, but more research is needed.
Plan hair-restoration surgery early for better results in male pattern baldness.
August 2013 in “Hospital Pharmacy” Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.
Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.
Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.
October 2012 in “Ain-Shams Journal of Surgery” The direction of hair implants doesn't affect the final direction of hair growth in baldness treatments.
March 2012 in “Dermatology Times E-News” Men with pattern baldness may have a higher risk of prostate issues.
September 2011 in “Hair transplant forum international” Hair transplants can be effective for early male pattern baldness.
Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.